Mepiblock 20 mg/ml solution for injection for horses Ireland - English - HPRA (Health Products Regulatory Authority)

mepiblock 20 mg/ml solution for injection for horses

dechra regulatory b.v. - mepivacaine hydrochloride - solution for injection - 20 milligram(s)/millilitre - mepivacaine

OXYCODONE-HAMELN oxycodone hydrochloride 50 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 50 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide; sodium chloride - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 10 mg/1 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 10 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 20 mg/2 mL injection solution ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 20 mg/2 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

sugammadex-teva sugammadex (as sodium) 200 mg/2 ml solution for injection vial

teva pharma australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

neostigmine juno neostigmine methylsulfate 2.5 mg/1 ml solution for injection ampoule

juno pharmaceuticals pty ltd - neostigmine methylsulfate, quantity: 2.5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - neostigmine is indicated for:,? reversal of the effects of non-depolarising neuromuscular blocking agents.,? prophylaxis and treatment of post-operative intestinal atony and urinary retention.,? treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.

VICTOZA liraglutide (rys) 6mg/mL solution for injection, pre-filled pen Australia - English - Department of Health (Therapeutic Goods Administration)

victoza liraglutide (rys) 6mg/ml solution for injection, pre-filled pen

novo nordisk pharmaceuticals pty ltd - liraglutide, quantity: 6 mg/ml - injection, solution - excipient ingredients: phenol; hydrochloric acid; water for injections; propylene glycol; dibasic sodium phosphate dihydrate; sodium hydroxide - glycaemic control,victoza is indicated as an adjunct to diet and exercise for treatment of adults with type 2 diabetes mellitus to achieve glycaemic control:,- as monotherapy when metformin is contraindicated or is not tolerated,- in combination with other glucose lowering medicines.,prevention of cardiovascular events,in patients where victoza is indicated to improve glycaemic control, victoza is indicated to reduce the risk of cardiovascular events in those at high cardiovascular risk, as an adjunct to standard of care therapy (see clinical trials).

BRIDION sugammadex 500 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bridion sugammadex 500 mg/5 ml solution for injection vial

merck sharp & dohme (australia) pty ltd - sugammadex sodium, quantity: 544 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

BRIDION sugammadex 200 mg/2 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bridion sugammadex 200 mg/2 ml solution for injection vial

merck sharp & dohme (australia) pty ltd - sugammadex sodium, quantity: 217.6 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

glyconeo 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 ml solution for injection ampoule

ksj pharmatech - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; citric acid; sodium hydroxide; dibasic sodium phosphate dodecahydrate - reversal of residual non-depolarising (competitive) neuromuscular block.